Dr Richard Perry

Dr Perry is a consultant neurologist and honorary senior lecturer at Imperial College London, with particular expertise in cognition, memory disorders, and traumatic brain injury. He is renowned for his focus on the early diagnosis and treatment of Alzheimer’s Disease and leads specialised memory clinics at Charing Cross Hospital.

Dr Perry developed his specialist clinical and research experience in cognition and memory disorders at the University of Cambridge Neurology Unit and the University of California, San Francisco, two of the leading institutions in neurological research and patient care. His dual expertise in both clinical practice and academic research allow him to deliver evidence-based care at the forefront of neurology.

Dr Perry has been the Principal or Chief Investigator at Imperial NHS Trust for many clinical trials of new medications for Alzheimer's Disease, including lecanemab, donanemab, and trontinemab. 

Dr Perry now practices at Cleveland Clinic London, where he provides expert care to patients with complex neurological conditions, ensuring a comprehensive and individualised approach to diagnosis and treatment. He is now using his many years of experience from clinical trial research, by leading the service for providing lecanemab and donanemab treatment to patients in a world class setting with state-of-the-art facilities.